ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
bullish•SK Inc
•04 Oct 2021 20:09

SK Inc - SoTP Valuation Analysis and 3 Key Catalysts (SK E&S, SK Pharmteco, & SK Siltron)

In this insight, we provide an updated NAV valuation analysis of SK Inc. Our updated base case valuation of SK Inc is 381,838 won per share,...

Logo
498 Views
Share
bullish•Krafton
•31 Aug 2021 17:21

KRX BBIG Index Rebalance: Krafton, SK Bioscience, SK IE Tech Included (Among Others)

Krafton has been added to the Game index, SK IE Tech added to the Battery index, SK Bioscience to the Bio index. Lots of flow on some names....

Logo
382 Views
Share
bullish•KakaoBank
•07 Aug 2021 17:53

Kakao Bank - MSCI Done, Missed FTSE by a Whisker.

Kakao Bank (KB), South Korea’s largest digital bank, raised US$2.2bn in its South Korean IPO. It ended the first day of trading up 79% from its IPO...

Logo
576 Views
Share
bullish•Krafton
•12 Jul 2021 08:01

A Guide to Notable Korean Sector Indices

Among the hundreds of local sector-themed indices, indices with significant AUM and passive impact are summarized in this post.

Logo
444 Views
Share
bearish•Kakao Games
•18 Jun 2021 11:18

KRX BBIG Index Rebalance Preview: Worth a Look

There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...

Logo
759 Views
Share
x